Cargando…

The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model

The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyer, Marlene, Gaul, Lisa-Marie, D`Agosto, Sabrina Luigia, Corbo, Vincenzo, Queiroz, Karla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185841/
https://www.ncbi.nlm.nih.gov/pubmed/37205118
http://dx.doi.org/10.3389/fimmu.2023.1155085
_version_ 1785042445281525760
author Geyer, Marlene
Gaul, Lisa-Marie
D`Agosto, Sabrina Luigia
Corbo, Vincenzo
Queiroz, Karla
author_facet Geyer, Marlene
Gaul, Lisa-Marie
D`Agosto, Sabrina Luigia
Corbo, Vincenzo
Queiroz, Karla
author_sort Geyer, Marlene
collection PubMed
description The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation of processes underlying the interaction between the tumor stroma, particularly activated pancreatic stellate cells (PSCs), and immune cells may offer new therapeutic approaches for PDAC treatment. In this study, we established a 3D PDAC model cultured under flow, consisting of an endothelial tube, PSCs and PDAC organoids. This was applied to study the role of the tumor microenvironment (TME) on immune cell recruitment and its effect on partly preventing their interaction with pancreatic cancer cells. We observed that stromal cells form a physical barrier, partly shielding the cancer cells from migrating immune cells, as well as a biochemical microenvironment, that seems to attract and influence immune cell distribution. In addition, stromal targeting by Halofuginone led to an increase in immune cell infiltration. We propose that the here developed model setups will support the understanding of the cellular interplay influencing the recruitment and distribution of immune cells, and contribute to the identification of key players in the PDAC immunosuppressive TME as well as support the discovery of new strategies to treat this immune unresponsive tumor.
format Online
Article
Text
id pubmed-10185841
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101858412023-05-17 The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model Geyer, Marlene Gaul, Lisa-Marie D`Agosto, Sabrina Luigia Corbo, Vincenzo Queiroz, Karla Front Immunol Immunology The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation of processes underlying the interaction between the tumor stroma, particularly activated pancreatic stellate cells (PSCs), and immune cells may offer new therapeutic approaches for PDAC treatment. In this study, we established a 3D PDAC model cultured under flow, consisting of an endothelial tube, PSCs and PDAC organoids. This was applied to study the role of the tumor microenvironment (TME) on immune cell recruitment and its effect on partly preventing their interaction with pancreatic cancer cells. We observed that stromal cells form a physical barrier, partly shielding the cancer cells from migrating immune cells, as well as a biochemical microenvironment, that seems to attract and influence immune cell distribution. In addition, stromal targeting by Halofuginone led to an increase in immune cell infiltration. We propose that the here developed model setups will support the understanding of the cellular interplay influencing the recruitment and distribution of immune cells, and contribute to the identification of key players in the PDAC immunosuppressive TME as well as support the discovery of new strategies to treat this immune unresponsive tumor. Frontiers Media S.A. 2023-05-02 /pmc/articles/PMC10185841/ /pubmed/37205118 http://dx.doi.org/10.3389/fimmu.2023.1155085 Text en Copyright © 2023 Geyer, Gaul, D`Agosto, Corbo and Queiroz https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Geyer, Marlene
Gaul, Lisa-Marie
D`Agosto, Sabrina Luigia
Corbo, Vincenzo
Queiroz, Karla
The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
title The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
title_full The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
title_fullStr The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
title_full_unstemmed The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
title_short The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
title_sort tumor stroma influences immune cell distribution and recruitment in a pdac-on-a-chip model
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185841/
https://www.ncbi.nlm.nih.gov/pubmed/37205118
http://dx.doi.org/10.3389/fimmu.2023.1155085
work_keys_str_mv AT geyermarlene thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT gaullisamarie thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT dagostosabrinaluigia thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT corbovincenzo thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT queirozkarla thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT geyermarlene tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT gaullisamarie tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT dagostosabrinaluigia tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT corbovincenzo tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel
AT queirozkarla tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel